DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 088297
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
NDA 088297 describes AMINOPHYLLINE, which is a drug marketed by Abraxis Pharm, Elkins Sinn, Hospira, Intl Medication, King Pharms, Luitpold, Lyphomed, Pharma Serve Ny, Smith And Nephew, Teva Parenteral, Morton Grove, Roxane, Impax Labs, Tablicaps, Vale, Ani Pharms Inc, Ascot, Barr, Duramed Pharms Barr, Halsey, Hikma Intl Pharms, Kv Pharm, Lannett, Pal Pak, Panray, Purepac Pharm, Valeant Pharm Intl, Vangard, Vintage Pharms, Watson Labs, and Actavis Mid Atlantic, and is included in fifty-eight NDAs. It is available from five suppliers. Additional details are available on the AMINOPHYLLINE profile page.
The generic ingredient in AMINOPHYLLINE is aminophylline. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the aminophylline profile page.
The generic ingredient in AMINOPHYLLINE is aminophylline. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the aminophylline profile page.
Summary for 088297
| Tradename: | AMINOPHYLLINE |
| Applicant: | Barr |
| Ingredient: | aminophylline |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 088297
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
| Approval Date: | Aug 19, 1983 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
